<?xml version="1.0" encoding="UTF-8"?>
<p>The first hope for HIV treatment occurred in 1987 when zidovudine, also known as AZT, was launched on the market [
 <xref rid="B8-pharmacy-08-00108" ref-type="bibr">8</xref>]. In the following years, other medications for the treatment of HIV received approval for human use. For example, in 1995 there were only five antiretrovirals, while in 2000 the market saw a sharp increase to nearly 16 medications [
 <xref rid="B9-pharmacy-08-00108" ref-type="bibr">9</xref>]. Furthermore, in 2018, at least 40 ART medications emerged on the U.S. market, in five different classes to select from for treatment [
 <xref rid="B10-pharmacy-08-00108" ref-type="bibr">10</xref>]. The main advantages of the newer medications are that they are less toxic, more tolerable than the initial ones, available in combinations, and dosed once daily [
 <xref rid="B11-pharmacy-08-00108" ref-type="bibr">11</xref>,
 <xref rid="B12-pharmacy-08-00108" ref-type="bibr">12</xref>]. 
</p>
